Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Impact of AT2 receptor deficiency on postnatal cardiovascular development.

Biermann D, Heilmann A, Didié M, Schlossarek S, Wahab A, Grimm M, Römer M, Reichenspurner H, Sultan KR, Steenpass A, Ergün S, Donzelli S, Carrier L, Ehmke H, Zimmermann WH, Hein L, Böger RH, Benndorf RA.

PLoS One. 2012;7(10):e47916. doi: 10.1371/journal.pone.0047916.

2.

Guanylyl cyclase-A inhibits angiotensin II type 2 receptor-mediated pro-hypertrophic signaling in the heart.

Li Y, Saito Y, Kuwahara K, Rong X, Kishimoto I, Harada M, Adachi Y, Nakanishi M, Kinoshita H, Horiuchi M, Murray M, Nakao K.

Endocrinology. 2009 Aug;150(8):3759-65. doi: 10.1210/en.2008-1353.

PMID:
19372206
3.

Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.

Masaki H, Kurihara T, Yamaki A, Inomata N, Nozawa Y, Mori Y, Murasawa S, Kizima K, Maruyama K, Horiuchi M, Dzau VJ, Takahashi H, Iwasaka T, Inada M, Matsubara H.

J Clin Invest. 1998 Feb 1;101(3):527-35.

4.

Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction.

Nakayama M, Yan X, Price RL, Borg TK, Ito K, Sanbe A, Robbins J, Lorell BH.

Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H317-27.

5.

Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I.

Frantz S, Klaiber M, Baba HA, Oberwinkler H, Völker K, Gaβner B, Bayer B, Abeβer M, Schuh K, Feil R, Hofmann F, Kuhn M.

Eur Heart J. 2013 Apr;34(16):1233-44. doi: 10.1093/eurheartj/ehr445.

6.

Phospholemman and beta-adrenergic stimulation in the heart.

Wang J, Gao E, Song J, Zhang XQ, Li J, Koch WJ, Tucker AL, Philipson KD, Chan TO, Feldman AM, Cheung JY.

Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H807-15. doi: 10.1152/ajpheart.00877.2009.

7.

Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.

Li Y, Kishimoto I, Saito Y, Harada M, Kuwahara K, Izumi T, Takahashi N, Kawakami R, Tanimoto K, Nakagawa Y, Nakanishi M, Adachi Y, Garbers DL, Fukamizu A, Nakao K.

Circulation. 2002 Sep 24;106(13):1722-8.

8.

Mechanical stretch induces hypertrophic responses in cardiac myocytes of angiotensin II type 1a receptor knockout mice.

Kudoh S, Komuro I, Hiroi Y, Zou Y, Harada K, Sugaya T, Takekoshi N, Murakami K, Kadowaki T, Yazaki Y.

J Biol Chem. 1998 Sep 11;273(37):24037-43.

9.

Deficiency of M2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress.

LaCroix C, Freeling J, Giles A, Wess J, Li YF.

Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H810-20.

10.

Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.

Klaiber M, Kruse M, Völker K, Schröter J, Feil R, Freichel M, Gerling A, Feil S, Dietrich A, Londoño JE, Baba HA, Abramowitz J, Birnbaumer L, Penninger JM, Pongs O, Kuhn M.

Basic Res Cardiol. 2010 Sep;105(5):583-95. doi: 10.1007/s00395-010-0098-z.

11.

Altered mRNA abundance of calcium transport genes in cardiac myocytes induced by angiotensin II.

Ju H, Scammel-La Fleur T, Dixon IM.

J Mol Cell Cardiol. 1996 May;28(5):1119-28.

PMID:
8762048
12.

Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts.

Gödecke A, Heinicke T, Kamkin A, Kiseleva I, Strasser RH, Decking UK, Stumpe T, Isenberg G, Schrader J.

J Physiol. 2001 Apr 1;532(Pt 1):195-204.

13.

Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation.

Gramolini AO, Trivieri MG, Oudit GY, Kislinger T, Li W, Patel MM, Emili A, Kranias EG, Backx PH, Maclennan DH.

Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2446-51.

14.

Cardiac overexpression of the human 5-HT4 receptor in mice.

Gergs U, Baumann M, Böckler A, Buchwalow IB, Ebelt H, Fabritz L, Hauptmann S, Keller N, Kirchhof P, Klöckner U, Pönicke K, Rueckschloss U, Schmitz W, Werner F, Neumann J.

Am J Physiol Heart Circ Physiol. 2010 Sep;299(3):H788-98. doi: 10.1152/ajpheart.00691.2009.

15.

Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart.

Lakó-Futó Z, Szokodi I, Sármán B, Földes G, Tokola H, Ilves M, Leskinen H, Vuolteenaho O, Skoumal R, deChâtel R, Ruskoaho H, Tóth M.

Circulation. 2003 Nov 11;108(19):2414-22.

16.

Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.

Mohamed BA, Barakat AZ, Zimmermann WH, Bittner RE, Mühlfeld C, Hünlich M, Engel W, Maier LS, Adham IM.

J Mol Cell Cardiol. 2012 Oct;53(4):459-68. doi: 10.1016/j.yjmcc.2012.07.014.

PMID:
22884543
17.

Dissociation of FKBP12.6 from ryanodine receptor type 2 is regulated by cyclic ADP-ribose but not beta-adrenergic stimulation in mouse cardiomyocytes.

Zhang X, Tallini YN, Chen Z, Gan L, Wei B, Doran R, Miao L, Xin HB, Kotlikoff MI, Ji G.

Cardiovasc Res. 2009 Nov 1;84(2):253-62. doi: 10.1093/cvr/cvp212.

18.

Increased β-adrenergic inotropy in ventricular myocardium from Trpm4-/- mice.

Mathar I, Kecskes M, Van der Mieren G, Jacobs G, Camacho Londoño JE, Uhl S, Flockerzi V, Voets T, Freichel M, Nilius B, Herijgers P, Vennekens R.

Circ Res. 2014 Jan 17;114(2):283-94. doi: 10.1161/CIRCRESAHA.114.302835.

19.

Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.

Wang N, Frank GD, Ding R, Tan Z, Rachakonda A, Pandolfi PP, Senbonmatsu T, Landon EJ, Inagami T.

PLoS One. 2012;7(4):e35632. doi: 10.1371/journal.pone.0035632.

20.

Increasing myocardial contraction and blood pressure in C57BL/6 mice during early postnatal development.

Tiemann K, Weyer D, Djoufack PC, Ghanem A, Lewalter T, Dreiner U, Meyer R, Grohe C, Fink KB.

Am J Physiol Heart Circ Physiol. 2003 Feb;284(2):H464-74.

Supplemental Content

Support Center